Animal models for hepatitis C

Area of Science:

• Virology
• Hepatology
• Immunology

Background:

• Hepatitis C virus (HCV) causes a global epidemic of chronic liver disease, including fibrosis, cirrhosis, and hepatocellular carcinoma (HCC).
• Current antiviral treatments for HCV are limited by partial effectiveness, high cost, and poor tolerability.
• The absence of a suitable small animal model significantly impedes research into HCV pathogenesis, immunity, and the development of novel therapies and vaccines.

Purpose of the Study:

• To review experimental approaches and advancements in developing small animal models for Hepatitis C virus (HCV).
• To discuss the challenges and promise of various models in understanding HCV-host interactions, immunity, and pathogenesis.
• To highlight how improved models can facilitate the development of effective prophylactic or therapeutic strategies against HCV.

Main Methods:

• Review of existing literature on experimental small animal models for HCV.
• Analysis of approaches to recapitulate aspects of the HCV life cycle and pathogenesis in vivo.
• Evaluation of the utility and limitations of non-primate models compared to chimpanzees.

Main Results:

• Numerous experimental strategies have been employed to create tractable small animal models for HCV research.
• Established and novel models show promise in partially replicating HCV infection dynamics and disease aspects.
• Progress in model development offers new avenues for mechanistic studies and therapeutic interventions.

Conclusions:

• The development of suitable small animal models is crucial for advancing our understanding of chronic Hepatitis C virus (HCV) infection.
• Current research efforts are focused on improving existing models and creating new ones to overcome limitations of chimpanzee studies.
• These improved models hold significant potential for elucidating HCV pathogenesis and accelerating the development of vaccines and treatments.